Safety and Efficacy of LCL161 in Patients With Solid Tumors
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the safety of increasing doses of oral LCL161 in patients with solid
tumors. It is primarily designed to evaluate the side effects and find the maximum tolerated
dose of LCL161.